{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:54Z","timestamp":1759017954062,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.annder.2018.02.015","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T08:39:42Z","timestamp":1525682382000},"page":"445-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pyoderma gangrenosum apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques"],"prefix":"10.1016","volume":"145","author":[{"given":"H.","family":"Eddou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ennouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zinebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"El Benaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K.","family":"Moudden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Doghmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-V.","family":"Malfuson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mikdame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"El Baaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.02.015_bib0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOH.0000000000000100","article-title":"Neutrophilic dermatosis: disease mechanism and treatment","volume":"22","author":"Maalouf","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.annder.2018.02.015_bib0140","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.02.015_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","article-title":"Pyoderma gangrenosum: a review","volume":"30","author":"Crowson","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2018.02.015_bib0150","first-page":"1","article-title":"Nouvelle contribution a l\u2019\u00e9tude du phag\u00e9d\u00e9nisme g\u00e9om\u00e9trique","volume":"6","author":"Brocq","year":"1916","journal-title":"Ann Dermatol Syphilligr"},{"key":"10.1016\/j.annder.2018.02.015_bib0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany; a retrospective multicen-tric analysis in 259\u00a0patients","volume":"8","author":"Al Ghazal","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.annder.2018.02.015_bib0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","article-title":"Pathophysiology of pyoderma gangrenosum (PG): an updated review","volume":"73","author":"Braswell","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.02.015_bib0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","article-title":"Role of inflammatory cells, cytokines and matrix metallo proteinases in neutrophil-mediated skin diseases","volume":"162","author":"Marzano","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.annder.2018.02.015_bib0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic auto-inflammatory skin diseases, pyoderma gangrenosum and sweet's syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.annder.2018.02.015_bib0175","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.bbmt.2016.04.005","article-title":"Immune-mediated complications after hematopoietic stem cell transplantation","volume":"22","author":"Li","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.annder.2018.02.015_bib0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","article-title":"Management of auto-immune diseases after haematopoietic stem cell transplantation","volume":"157","author":"Holbro","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2018.02.015_bib0185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3109\/10428194.2012.762978","article-title":"Pharmacologic prophylaxis regimens for Acute GVHD Past, Present and Future","volume":"54","author":"Ram","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.annder.2018.02.015_bib0190","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3324\/haematol.2016.149294","article-title":"A prospective randomized trial comparing cyclosporine\/methotrexate and tacrolimus\/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"T\u00f6rl\u00e9n","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.annder.2018.02.015_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbmt.2011.12.583","article-title":"Graft-versus-host diseaseprophylaxis: does drug dosage matter?","volume":"18","author":"Soci\u00e9","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.annder.2018.02.015_bib0200","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.annder.2015.06.007","article-title":"Developments in pyoderma gangrenosum therapy in 2015","volume":"142","author":"Modiano","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.02.015_bib0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1529-8019.2012.01488.x","article-title":"Management of neutrophilic dermatoses","volume":"25","author":"Schadt","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2018.02.015_bib0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014\u00a0Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.annder.2018.02.015_bib0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in ChronicGraft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.annder.2018.02.015_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijd.13381","article-title":"Cutaneous manifestations of graft-versus-host disease: role of the dermatologist","volume":"56","author":"Kavand","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2018.02.015_bib0225","first-page":"827","volume":"5","author":"Wollina","year":"2017"},{"key":"10.1016\/j.annder.2018.02.015_bib0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10354-014-0285-x","article-title":"Pyoderma gangrenosum: pathogenetic oriented treatment approaches","volume":"164","author":"Wollina","year":"2014","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.annder.2018.02.015_bib0235","first-page":"e270","volume":"58","author":"Benzaquen","year":"2017"},{"key":"10.1016\/j.annder.2018.02.015_bib0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cgh.2016.06.025","article-title":"Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease","volume":"15","author":"Peyrin-Biroulet","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annder.2018.02.015_bib0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/bjd.14037","article-title":"Canakinumab in adults with steroid-refractory pyoderma gangrenosum","volume":"173","author":"Kolios","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.02.015_bib0250","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jdcr.2016.07.007","article-title":"The role of interleukin-1\u03b2 in pyoderma gangrenosum","volume":"2","author":"Galimberti","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2018.02.015_bib0255","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/dth.12387","article-title":"High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum","volume":"29","author":"Greb","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2018.02.015_bib0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jdcr.2017.02.019","article-title":"Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum","volume":"3","author":"Laird","year":"2017","journal-title":"JAAD Case Rep"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818303430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818303430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:06Z","timestamp":1758971166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818303430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":26,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0151963818303430"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.02.015","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyoderma gangrenosum apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}